Abcede, Maria T.

HRN: 06-36-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/04/2025
01/12/2025
IV
4.5gm
Q6h
Cap Hr; Urosepsis
Waiting Final Action 
01/11/2025
MUPIROCIN 2%, 15G (TUBE)
01/11/2025
01/17/2025
TOPICAL
Apply On Affected Areas
Bid
Soft Tissue Infection
Waiting Final Action 
01/13/2025
CEFTAZIDIME 1GM (VIAL)
01/13/2025
01/19/2025
IVT
2g
Q8H
CAP MR
Waiting Final Action 
01/13/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/13/2025
01/19/2025
IVT
600mg
Q8H
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: